FdaApplication
ANDA 205913
Identifiers
- fda_app_no: ANDA205913
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS OF NEW YORK LLC |
| application_type | ANDA |
| approval_date | 2018-06-19 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PRASUGREL | PRASUGREL HYDROCHLORIDE | EQ 10MG BASE | TABLET;ORAL |
| PRASUGREL | PRASUGREL HYDROCHLORIDE | EQ 5MG BASE | TABLET;ORAL |
2 products